Skip to main content
Skip to list of reports Filters

Date Range

Reports

Search reports, investigative results, and agency plansShowing 1 - 10 of 50 results
Special Inspector General for Pandemic Recovery

Independent Review of Executive Compensation: Yellow Corporation

The objective of this audit is to determine whether Yellow, and its affiliates, complied with executive compensation limits under Section 12.05 of its Loan and Guarantee Agreement with the U.S. Department of the Treasury. 

Special Inspector General for Pandemic Recovery

Compilation of Lessons Learned Report

The objective of the report is to compile SIGPR's audit products as well as lessons learned related to SIGPR's budget, jurisdiction, and hiring authority.

Special Inspector General for Pandemic Recovery

Audit of Risk Factor Mitigation in MSLP Loans

The objective of this review is to develop other MSLP audit ideas derived from our data analytics platform and risk assessment. 

Special Inspector General for Pandemic Recovery

Independent Review of Direct Loan Recipient: Map Large Inc.

The objective of the audit is to determine if Map Large follows the terms and conditions of its direct loan agreement. 

Special Inspector General for Pandemic Recovery

Audit of the Effects the MSLP’s Loan Losses Have on Treasury’s Investment

The Federal Reserve Bank of Boston manages the Main Street Lending Program (MSLP) through a Special Purpose Vehicle, which is backed by a $16.6 billion equity investment by Treasury. SIGPR will issue cyclical interim reports to Treasury on the information gathered from the various banks that participate in the MSLP.

Special Inspector General for Pandemic Recovery

Audit of the Main Street Lending Program

The Office of the Special Inspector General for Pandemic Recovery is evaluating funds that were allocated to the Federal Reserve System’s Main Street Lending Program (MSLP), which had 319 lenders and 1,830 borrowers participating in loans totaling more than $17 billion. The objectives of the audit are to 1) assess the process used by banks to issue loans under the MSLP program; 2) evaluate the process used by the Federal Reserve’s Special Purpose Vehicle to purchase the loans;  3) determine vulnerabilities based on a risk-based analysis; and 4) identify specific areas that warrant further audit work.
 

Department of Health & Human Services OIG

Audit of Health Resources and Services Administration's COVID-19 Supplemental Grant Funding for Health Centers

The Health Resources and Services Administration (HRSA) awarded nearly $2 billion in supplemental grant funding to 1,387 health centers nationwide in fiscal year (FY) 2020 to respond to the COVID-19 public health emergency. The funding was intended to support the health centers' activities related to the detection, prevention, diagnosis, and treatment of COVID-19, including maintaining or increasing health center capacity and staffing levels during the pandemic, and expanding COVID-19 testing. The performance period for each of these one-time supplemental grant awards, which HRSA began awarding in March 2020, is 12 months. Health centers were permitted to charge to their awards pre-award costs in order to support expenses related to the COVID-19 public health emergency dating back to January 20, 2020. We will determine whether health centers used their HRSA COVID-19 supplemental grant funding in accordance with Federal requirements and grant terms.

Department of Health & Human Services OIG

Yearend Review of Opioid Use in Medicare Part D in 2020

Identifying patients who are at-risk of overdose or abuse is key to addressing this crisis. The COVID-19 pandemic has made this need even more pressing. The National Institutes of Health recently warned that individuals with opioiduse disorder could be particularly hard hit by COVID-19, which is a respiratory virus that attacks the lungs. Respiratory disease is known to increase mortality risks among people taking opioids. This data brief would provide information on opioid utilization among beneficiaries enrolled in Medicare Part D in 2020. 

Department of Health & Human Services OIG

Awardee Challenges in Implementing COVID_19 Vaccination Program

CDC Immunization and Vaccines for Children Cooperative Agreement awardees, which are typically State and large metropolitan area public health departments, plan for and oversee the vaccine distribution and administration process. Stakeholders have acknowledged challenges early in Phase 1 distribution and dispensing, and note that these challenges will likely span all three phases identified in the CDC's COVID-19 Vaccine Playbook. We will interview all awardees to identify the reported challenges they are facing while distributing and dispensing vaccines. We will also ask awardees about effective strategies to mitigate those challenges, new challenges they anticipate, and how HHS can best support them in distributing and dispensing COVID-19 vaccines. In doing so, this review will provide HHS with timely and actionable information to address challenges associated with the COVID-19 vaccination efforts.

Special Inspector General for Pandemic Recovery

Audit of the Direct Loan Program

The Office of the Special Inspector General for Pandemic Recovery is assessing the Department of the Treasury's Direct Loan Program, which provided approximately $2.7 billion through 35 loans to passenger air carriers and related businesses, cargo air carriers, and businesses critical to maintaining national security. The objectives of the audit are to 1) determine if the processes to approve loans followed requirements under Section 4003(b) of the CARES Act and other appropriate regulations and guidance and 2) evaluate Treasury’s Direct Loan Program loan portfolio management process and determine whether it follows best practices established by the Office of the Comptroller of the Currency or other appropriate authority. As part of this effort, SIGPR is partnering with the Department of Defense OIG in reviewing the loans that were issued in the interest of national security.